During the past decade, National Institute of Endocrinology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Institute of Endocrinology" are "Acromegaly" (1 trials) and "Gastroparesis" (1 trials). Many other conditions were trialed in "National Institute of Endocrinology" in a lesser frequency.

Most popular intervention types in "National Institute of Endocrinology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lanreotide PRF" (1 trials) and "Relamorelin 10 μg" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Endocrinology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Institute of Endocrinology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in National Institute of Endocrinology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Endocrinology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".